A-shares closed · 港股休市 Quotes 行情 · 28 Sep 16:29 CST
28 Sep 2026 · 19:57 CST Terminal Access 终端入口 →
600771.SH上海证券交易所 · 主板 Main

Guangyuyuan 广誉远

Traditional Chinese Medicine 中药Ⅱ
¥14.04+¥0.39 · +2.86%Delayed 行情延迟 · 28 Sep 2026 · 16:14 CST · CNY
Open 开盘
¥13.69
High 最高
¥14.29
Low 最低
¥13.59
Prev Close 昨收
¥13.65
Volume 成交量
1,366.3万股
Turnover 成交额
¥1.91亿
Mkt Cap 总市值
¥69亿
P/E 市盈率
97.0×
Recent Activity 近期动态All Filings 全部公告 →

3 significant filings since 31 May 2026: 1 on litigation, 1 on government subsidy and 1 on buyback. The latest, on 15 Jul 2026: 广誉远中药股份有限公司关于重大诉讼的进展公告. 1 unverified report logged, the latest on 11 Jun 2026.
自 31 May 2026 起有 3 份重大公告:litigation 1 份、government subsidy 1 份、buyback 1 份。最新一份(15 Jul 2026):广誉远中药股份有限公司关于重大诉讼的进展公告。记录了 1 条未经核实的报道,最新一条见于 11 Jun 2026。

Price History 价格走势

6,987 trading days 个交易日 · High 最高 ¥53.35 · Low 最低 ¥1.11
10.0020.0030.0040.0050.00
Volume 成交量
6,988.6万
19962004201120192026
Last Twelve Months 近十二个月

No broker reports from the last twelve months are held for this company. Brokers covered 1,185 of the 2,361 SSE listings (50%) over the same period. 近十二个月无本公司研报;同期券商覆盖了 2,361 只 SSE 证券中的 1,185 只(50%)。

Rating Changes 评级变动
2 up · 0 down in all reports held 全部研报中上调 2 次,下调 0 次
Date 日期Broker 券商Analyst 分析师From 原评级To 新评级
15 May 2018东兴证券张金洋,缪牧一Outperform 增持▲Buy 买入
24 Apr 2018联讯证券李志新Outperform 增持▲Buy 买入

Each broker's rating is compared with its previous report. 每家券商的评级与其上一份研报比较。

Coverage by Quarter 覆盖变化
0 23Q4
0 24Q1
0 24Q2
0 24Q3
0 24Q4
0 25Q1
1 25Q2
0 25Q3
0 25Q4
0 26Q1
0 26Q2
0 26Q3

Each bar counts the brokers publishing on this company in a quarter. The latest quarter is not yet complete. 每根柱为该季度发布本公司研报的券商数,最近一个季度尚未结束。